Insights Into Boston Scientific (BSX) Q3: Wall Street Projections for Key MetricsZacks Investment Research · 2 days ago
Boston Scientific Corporation $BSX Stock Bought by Integrated Advisors Network LLCDefense World · 2 days ago
Boston Scientific: A Q3 Earnings Miss Likely Amid Product Recall, Cybersecurity IncidentSeeking Alpha · 2 days ago
BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation's Directors and Officers for Breach of Fiduciary Duties -- BSXGuruFocus · 3 days ago
BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation's Directors and Officers for Breach of Fiduciary Duties – BSXBusiness Wire · 3 days ago
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research · 3 days agoBoston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 29, 2026 | $0.84 | $0.86 | Beat |
| Apr 22, 2026 | $0.79 | $0.80 | Beat |
| Feb 4, 2026 | $0.78 | $0.80 | Beat |
| Oct 22, 2025 | $0.71 | $0.75 | Beat |
| Jul 23, 2025 | $0.73 | $0.75 | Beat |
| Apr 23, 2025 | $0.67 | $0.75 | Beat |